Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study
The Lancet infectious diseases, 2012•thelancet.com
Background Hormonal contraceptives are used widely but their effects on HIV-1 risk are
unclear. We aimed to assess the association between hormonal contraceptive use and risk
of HIV-1 acquisition by women and HIV-1 transmission from HIV-1-infected women to their
male partners. Methods In this prospective study, we followed up 3790 heterosexual HIV-1-
serodiscordant couples participating in two longitudinal studies of HIV-1 incidence in seven
African countries. Among injectable and oral hormonal contraceptive users and non-users …
unclear. We aimed to assess the association between hormonal contraceptive use and risk
of HIV-1 acquisition by women and HIV-1 transmission from HIV-1-infected women to their
male partners. Methods In this prospective study, we followed up 3790 heterosexual HIV-1-
serodiscordant couples participating in two longitudinal studies of HIV-1 incidence in seven
African countries. Among injectable and oral hormonal contraceptive users and non-users …
Background
Hormonal contraceptives are used widely but their effects on HIV-1 risk are unclear. We aimed to assess the association between hormonal contraceptive use and risk of HIV-1 acquisition by women and HIV-1 transmission from HIV-1-infected women to their male partners.
Methods
In this prospective study, we followed up 3790 heterosexual HIV-1-serodiscordant couples participating in two longitudinal studies of HIV-1 incidence in seven African countries. Among injectable and oral hormonal contraceptive users and non-users, we compared rates of HIV-1 acquisition by women and HIV-1 transmission from women to men. The primary outcome measure was HIV-1 seroconversion. We used Cox proportional hazards regression and marginal structural modelling to assess the effect of contraceptive use on HIV-1 risk.
Findings
Among 1314 couples in which the HIV-1-seronegative partner was female (median follow-up 18·0 [IQR 12·6–24·2] months), rates of HIV-1 acquisition were 6·61 per 100 person-years in women who used hormonal contraception and 3·78 per 100 person-years in those who did not (adjusted hazard ratio 1·98, 95% CI 1·06–3·68, p=0·03). Among 2476 couples in which the HIV-1-seronegative partner was male (median follow-up 18·7 [IQR 12·8–24·2] months), rates of HIV-1 transmission from women to men were 2·61 per 100 person-years in couples in which women used hormonal contraception and 1·51 per 100 person-years in couples in which women did not use hormonal contraception (adjusted hazard ratio 1·97, 95% CI 1·12–3·45, p=0·02). Marginal structural model analyses generated much the same results to the Cox proportional hazards regression.
Interpretation
Women should be counselled about potentially increased risk of HIV-1 acquisition and transmission with hormonal contraception, especially injectable methods, and about the importance of dual protection with condoms to decrease HIV-1 risk. Non-hormonal or low-dose hormonal contraceptive methods should be considered for women with or at-risk for HIV-1.
Funding
US National Institutes of Health and the Bill & Melinda Gates Foundation.
thelancet.com